# Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Haemorrhage (IMASH)

> **NCT00124150** · PHASE3 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 327 (actual)

## Conditions studied

- Subarachnoid Hemorrhage

## Interventions

- **DRUG:** Intravenous magnesium sulfate infusion

## Key facts

- **NCT ID:** NCT00124150
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2008-12
- **Final completion:** 2009-06
- **Target enrollment:** 327 (ACTUAL)
- **Last updated:** 2009-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00124150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00124150, "Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Haemorrhage (IMASH)". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT00124150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*